FMED vs. XLVI
FMED (Fidelity Disruptive Medicine ETF) and XLVI (State Street Health Care Select Sector SPDR Premium Income ETF) are both exchange-traded funds - FMED is a Health & Biotech Equities fund actively managed by Fidelity, while XLVI is a Derivative Income fund actively managed by State Street. Both are actively managed. A 0.59 correlation means they provide meaningful diversification when combined. FMED charges 0.50%/yr vs 0.35%/yr for XLVI.
Performance
FMED vs. XLVI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, FMED achieves a -2.44% return, which is significantly lower than XLVI's 2.50% return.
FMED
- 1D
- 1.03%
- 1M
- 6.62%
- YTD
- -2.44%
- 6M
- -4.06%
- 1Y
- 12.97%
- 3Y*
- 1.97%
- 5Y*
- —
- 10Y*
- —
XLVI
- 1D
- 1.53%
- 1M
- 2.15%
- YTD
- 2.50%
- 6M
- 2.57%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
FMED vs. XLVI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
FMED Fidelity Disruptive Medicine ETF | -2.44% | 13.11% |
XLVI State Street Health Care Select Sector SPDR Premium Income ETF | 2.50% | 12.41% |
Correlation
The correlation between FMED and XLVI is 0.59, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Jul 30, 2025 | 0.59 |
FMED vs. XLVI - Sectors Allocation Comparison
Sectors
FMED
XLVI
Healthcare
Technology
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
Industrials
-
-
Real Estate
-
-
Utilities
-
-
Healthcare
FMED
XLVI
Technology
FMED
XLVI
-
Basic Materials
FMED
-
XLVI
-
Communication Services
FMED
-
XLVI
-
Consumer Cyclical
FMED
-
XLVI
-
Consumer Defensive
FMED
-
XLVI
-
Energy
FMED
-
XLVI
-
Financial Services
FMED
-
XLVI
Industrials
FMED
-
XLVI
-
Real Estate
FMED
-
XLVI
-
Utilities
FMED
-
XLVI
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
FMED vs. XLVI — Risk / Return Rank
FMED
XLVI
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
FMED vs. XLVI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity Disruptive Medicine ETF (FMED) and State Street Health Care Select Sector SPDR Premium Income ETF (XLVI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| FMED | XLVI | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.13 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 0.71 | — | — |
| Martin ratioReturn relative to average drawdown | 1.55 | — | — |
Loading charts...
Drawdowns
FMED vs. XLVI - Drawdown Comparison
The maximum FMED drawdown since its inception was -21.84%, which is greater than XLVI's maximum drawdown of -8.14%. Use the drawdown chart below to compare losses from any high point for FMED and XLVI.
Loading charts...
Drawdown Indicators
| FMED | XLVI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -21.84% | -8.14% | -13.70% |
Max Drawdown (1Y)Largest decline over 1 year | -18.33% | — | — |
Max Drawdown (3Y)Largest decline over 3 years | -21.84% | — | — |
Current DrawdownCurrent decline from peak | -8.48% | -0.97% | -7.51% |
Average DrawdownAverage peak-to-trough decline | -7.11% | -1.94% | -5.17% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.38% | — | — |
Volatility
FMED vs. XLVI - Volatility Comparison
Loading charts...
Volatility by Period
| FMED | XLVI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.57% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 15.04% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 19.27% | 11.06% | +8.21% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.53% | 11.06% | +7.47% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.53% | 11.06% | +7.47% |
FMED vs. XLVI - Expense Ratio Comparison
FMED has a 0.50% expense ratio, which is higher than XLVI's 0.35% expense ratio.
Dividends
FMED vs. XLVI - Dividend Comparison
FMED has not paid dividends to shareholders, while XLVI's dividend yield for the trailing twelve months is around 11.17%.
| Position | TTM | 2025 | 2024 |
|---|---|---|---|
FMED Fidelity Disruptive Medicine ETF | 0.00% | 0.00% | 0.46% |
XLVI State Street Health Care Select Sector SPDR Premium Income ETF | 11.17% | 5.73% | 0.00% |
Frequently Asked Questions
FMED and XLVI have a correlation of 0.59, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, XLVI is cheaper at 0.35% per year. The better choice depends on whether you care most about return, fees, risk, or income.
XLVI is cheaper with a 0.35% expense ratio, compared with 0.50% for FMED.
XLVI has the higher dividend yield at 11.17%, compared with 0.00% for FMED.
FMED is categorized as Health & Biotech Equities, while XLVI is Derivative Income. They also come from different issuers: Fidelity and State Street. Their fees differ too: 0.50% for FMED and 0.35% for XLVI.
Find the right allocation for FMED and XLVI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer